170 related articles for article (PubMed ID: 22363796)
1. Urokinase plasminogen receptor and the fibrinolytic complex play a role in nerve repair after nerve crush in mice, and in human neuropathies.
Rivellini C; Dina G; Porrello E; Cerri F; Scarlato M; Domi T; Ungaro D; Del Carro U; Bolino A; Quattrini A; Comi G; Previtali SC
PLoS One; 2012; 7(2):e32059. PubMed ID: 22363796
[TBL] [Abstract][Full Text] [Related]
2. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci; 2001 Jun; 21(12):4336-47. PubMed ID: 11404419
[TBL] [Abstract][Full Text] [Related]
3. Urokinase receptor regulates nerve regeneration through its interaction with α5β1-integrin.
Klimovich PS; Semina EV; Karagyaur MN; Rysenkova KD; Sysoeva VY; Mironov NA; Sagaradze GD; Az'muko AA; Popov VS; Rubina KA; Tkachuk VA
Biomed Pharmacother; 2020 May; 125():110008. PubMed ID: 32187956
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
[TBL] [Abstract][Full Text] [Related]
6. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
Neuss S; Schneider RK; Tietze L; Knüchel R; Jahnen-Dechent W
Cells Tissues Organs; 2010; 191(1):36-46. PubMed ID: 19390164
[TBL] [Abstract][Full Text] [Related]
7. Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation.
Connolly BM; Choi EY; Gårdsvoll H; Bey AL; Currie BM; Chavakis T; Liu S; Molinolo A; Ploug M; Leppla SH; Bugge TH
Blood; 2010 Sep; 116(9):1593-603. PubMed ID: 20466854
[TBL] [Abstract][Full Text] [Related]
8. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
Idell S
Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
[TBL] [Abstract][Full Text] [Related]
9. Urokinase mediates fibrinolysis in the pulmonary microvasculature.
Bdeir K; Murciano JC; Tomaszewski J; Koniaris L; Martinez J; Cines DB; Muzykantov VR; Higazi AA
Blood; 2000 Sep; 96(5):1820-6. PubMed ID: 10961882
[TBL] [Abstract][Full Text] [Related]
10. The extracellular matrix affects axonal regeneration in peripheral neuropathies.
Previtali SC; Malaguti MC; Riva N; Scarlato M; Dacci P; Dina G; Triolo D; Porrello E; Lorenzetti I; Fazio R; Comi G; Bolino A; Quattrini A
Neurology; 2008 Jul; 71(5):322-31. PubMed ID: 18663178
[TBL] [Abstract][Full Text] [Related]
11. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.
Simon DI; Rao NK; Xu H; Wei Y; Majdic O; Ronne E; Kobzik L; Chapman HA
Blood; 1996 Oct; 88(8):3185-94. PubMed ID: 8874219
[TBL] [Abstract][Full Text] [Related]
12. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.
Bai X; Weitz JI; Gross PL
Thromb Haemost; 2009 Dec; 102(6):1212-8. PubMed ID: 19967153
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.
Shanmukhappa K; Sabla GE; Degen JL; Bezerra JA
BMC Gastroenterol; 2006 Nov; 6():40. PubMed ID: 17134505
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.
Wu F; Catano M; Echeverry R; Torre E; Haile WB; An J; Chen C; Cheng L; Nicholson A; Tong FC; Park J; Yepes M
J Neurosci; 2014 Oct; 34(43):14219-32. PubMed ID: 25339736
[TBL] [Abstract][Full Text] [Related]
16. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci Res; 2003 Nov; 74(3):430-4. PubMed ID: 14598319
[TBL] [Abstract][Full Text] [Related]
17. The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.
Tucker TA; Idell S
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535429
[TBL] [Abstract][Full Text] [Related]
18. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
19. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
[TBL] [Abstract][Full Text] [Related]
20. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
Del Rosso A; Cinelli M; Guiducci S; Pignone A; Fibbi G; Margheri F; Gabrielli A; Giacomelli R; Coppini A; Del Rosso M; Matucci Cerinic M
Rheumatology (Oxford); 2005 Oct; 44(10):1255-62. PubMed ID: 15998634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]